The aim of this study was to investigate whether NGF could reverse the nerve fiber atrophy exhibited by some neurons in old age. We used quantitative immunohistochemical techniques to investigate how the autonomic nerves that supply different blood vessels are affected by aging. Age changes in the nerve plexus were not widespread but were specific to particular vascular targets. Furthermore, where nerve fiber atrophy did occur, it affected different populations of nerves; specifically, sympathetic nerve fibers were lost from the middle cerebral artery while nonsympathetic nerves were lost from the tail vein. Peripheral target tissues have been shown to have a trophic influence on the pattern and density of their innervation, which declines in old age (Gavazri et al., 1992) , possibly as a result of decreased availability of neurotrophic factors such as NGF. Consequently, in an attempt to reverse nerve fiber atrophy, we used miniosmotic pumps to infuse NGF for 2 weeks over involuting nerve fibers in the middle cerebral artery of freely moving aged rats. Our results show that exogenous NGF can induce organotypic neurite outgrowth from aged neurons undergoing nerve fiber atrophy. Moreover, NGF can induce a change in the pattern of the old nerve plexus to one similar to that seen in young animals. NGF had different effects on the extent and manner of neurite outgrowth in young and aged nerves. NGF induced greater nerve growth in old compared to young nerves, causing old nerves to grow within existing nerve bundles and to sprout new nerve fibers, in contrast to young nerves, which tended to grow only within existing nerve bundles.
In conclusion, this study shows the potential of exogenous NGF to reverse age-related changes in neuronal morphology. [Key words: NGF, aging, atrophy, plasticity, peripheral nerve, autonomic nerves, neurodegeneration, sympathetic nerves, cerebral
blood vessels]
The heterogeneous appearance of neuronal atrophy is a prominent feature of the aged nervous system. Age-related neuronal changes in the PNS (Giacobini, 1988; Cowen, 1993a) and CNS (Wright et al., 1991; Selkoe, 1992) show both spatial and temporal specificity. A fundamental question in studies of aging is whether neuronal atrophy is primarily a result of intrinsic changes in the neuron or a result of changes in its external environment (Cowen, 1993b; Finch, 1993) . A recent study using transplantation has shown that age-related nerve fiber atrophy in the PNS can be caused by a loss of trophic support from peripheral target tissues (Gavazzi et al., 1992) . The role of extrinsic factors in neuronal aging has received further support from studies showing that aged peripheral neurons are not impaired in their capacity for neurite outgrowth (Crutcher, 1990; Suhonen et al., 1991; Gavazzi and Cowen, 1993a) . Decreased availability of target-derived NGF has been proposed as a factor in age-related neurodegenerative diseases (Appel, 198 1; Bartus et al., 1982; Perez-Polo et al., 1990) . However, a proven relationship between levels of NGF in target tissues and neuronal atrophy has yet to be established.
Target tissues influence the phenotype and survival of their innervating neurons via the production of neurotrophic factors (Levi-Montalcini, 1987; Purves, 1988) . NGF is the best characterized neurotrophic factor (Bjerre et al., 1975; Yankner and Shooter, 1982; Thoenen, 1991) , the role of which was first established in sympathetic and sensory neurons (Levi-Montalcini and Hamburger, 195 1; Levi-Montalcini and Booker, 1960) and later in CNS neurons (Seiler and Schwab, 1984) . NGF treatment in vivo can induce nerve growth from young and adult neurons (Snider, 1988; Isaacson et al., 1990; Ruit and Snider, 199 1; Zettler et al., 199 1) . However, it is not known whether NGF can induce nerve growth from aged neurons in vivo. In vitro studies provide conflicting evidence. Some studies show that NGF is able to elicit neurite outgrowth from aged sympathetic and sensory neurons but to a lesser extent than that seen in young neurons (Uchida and Tomonaga, 1985a,b; Hellweg et al., 1990) , while others show that neurite outgrowth of aged sensory neurons is unaffected by NGF (Fukuda et al., 199 1) .
In this study we aimed first to identify where nerve fiber atrophy occurs during aging and second, to investigate whether exogenous NGF can reverse this fiber atrophy. The perivascular nerve plexus can contain both sympathetic and sensory neurons, which depend on NGF for trophic support. Vascular smooth muscle, which is a target of these nerves, has been shown to produce NGF (Creedon and Tuttle, 199 1) . We hypothesize that age-related fiber atrophy seen in these perivascular nerves can be caused by loss of neurotrophic support provided by their targets. Histochemical and immunohistochemical markers for neuroactive substances have been widely used to study agerelated or experimentally induced changes in neuronal morphology (Dhall et al., 1986; Mione et al., 1988) . However, be-cause neurotransmitter expression can be affected by old age (Kedzierski and Porter, 1990) or experimental manipulations such as NGF infusion (Thoenen et al., 1971; Lindsay et al., 1989) , there is a risk of confusing changes in the levels of neureactive substances with nerve growth or atrophy. Antibodies to PGP9.5, a general neuronal marker, may help to overcome this problem (Gulbenkian et al., 1987; Wilson et al., 1988) . A previous study using PGP9.5 showed that the nerve plexuses of the posterior cerebral artery exhibit atrophy combined with reduced levels of transmitter (Cowen and Thrasivoulou, 1990) . Furthermore, PGP9.5 has been shown to record accurately agerelated atrophy in the innervation of human skin (Abdel-Rahman et al., 1992) . In the present study, noradrenaline histochemistry was used to detect age changes in perivascular sympathetic nerves (Todd, 1980; . Established methods of image analysis were employed to quantify nerve density Cowen and Thrasivoulou, 1992) . We used miniosmotic pumps to infuse exogenous NGF over the peripheral nerve plexuses around the cerebral arteries of freely moving young and old rats. Our results suggest that NGF can induce neurite outgrowth from perivascular nerves undergoing age-related atrophy.
Materials and Methods
Sprague-Dawley rats were killed at 6 weeks, 7 months, 18 months, and 24 months of age. Six weeks represents an age when the animals are sexually mature and the perivascular nerve plexus established. At 7 months the animals had achieved maximum body length and were fully mature but not aged; 18 and 24 months represent two different stages of the aging process. At 24 months the animals were senile, mortality ranging from 30% to 50% of the population. The innervation of five blood vessels, the middle cerebral and basilar arteries, the superior vena cava, and the portal and tail veins, was studied using indirect immunohistochemistry for the general neuronal marker PGP9.5 and glyoxylic acid histochemistry (Lindvall and Bjorklund, 1974) to demonstrate noradrenergic nerves. Animals were given an overdose of pentobarbitone sodium (500 mg/kg) and perfused through the heart with Tyrode's solution before tissue was taken for histochemical and immunohistochemical processing.
NGF infusion. Following the demonstration of nerve fiber atrophy in the nerve plexuses of the middle cerebral artery, these nerves were treated with exogenous NGF. Rats were used at 6 weeks and 24 months of age to compare the effects of NGF on young and aged nerves. Under deep halothane anesthesia, rats were fixed in a stereotaxic head frame. A sagittal scalp incision was made along the midline. The scalp and the temporal muscle on the left side were retracted laterally. A bone window was drilled below the sagittal suture and between the coronal and lambdoid sutures. The middle cerebral artery was identified and the dura over the artery incised. A catheter connected to a miniosmotic pump (Charles Riner Ltd., UK, pump 2002) was inserted subdurally next to the artery so that it could perfuse NGF over the nerves on the adventitial surface of the vessel. The pump was sutured subcutaneously between the scapulae, the incision closed and the rats allowed to recover. Neither old nor young animals displayed any infection or other problems following the operation. Animals fed and behaved normally. Two hundred microliters of NGF (100 &ml; Boehringer, UK) or vehicle containing cytochrome C (cyt C; 100 &ml; Calbiochem, UK) were infused for 14 d in freely moving rats. NGF and cytochrome C were dissolved in PBS containing 1% rat albumin (Sigma). At the end of the experiment, animals were killed with an overdose of pentobarbitone sodium (500 mg/ kg) and perfused through the heart with Tyrode's solution followed by 4% paraformaldehyde in PIPES buffer. Cerebral arteries were removed and processed for PGP9.5 immunohistochemistry.
PGP immunohistochemistry PGP9.5 immunohistochemistry was used to detect all nerve groups of the perivascular nerve plexus. Vessels were removed quickly and immersed in 4% paraformaldehyde for 2 hr. An eyepiece graticule was used in the dissecting microscope to stretch the vessels to their in vivo dimensions before uinnina onto silicone rubber arteries were opened and pinned adventitial side up. Vessels were washed in PBS and treated with 0.1% Triton X-100 and 80% alcohol to enhance penetration of antibodies. Conventional immunohistochemical procedures were used to process the specimens; 5% swine serum in PBS was applied for 2 hr followed by anti-PGP9.5 (Ultraclone, UK) diluted 1:400, overnight, and a fluorescein isothiocyanate (FITC)-conjugated swine anti-rabbit IgG (Dako) diluted 1:80, for 2 hr. Antibodies were diluted in PBS containing 1% swine serum. 0.1% sodium azide, and 0.1% Triton. Vessels were counterstained with 0.05% pontamine sky blue (BDH, UK) (Cowen et al., 1985) for 10 min, restretched to their in vivo dimensions over mica strips, and mounted in an antifade mountant (Citifluor, UK).
Noradrenaline histochemistry. Cerebral arteries were removed and quickly stretched to in vivo dimensions on Sylgard, while larger vessels were opened and pinned adventitial side up. Specimens were incubated in a 2% glyoxylic acid solution in phosphate buffer (pH 7.2) at room temperature for 90 min. For the last 10 min 0.05% pontamine sky blue was added to the incubation solution. The vessels were then stretched on mica, placed in a chamber at 80% humidity for 15 min and then in an oven at 80°C for 5 min, and finally mounted on microscope slides in liquid paraffin.
Light microscopical image analysis. Specimens were observed with an Olympus Vanox AH-2 fluorescence microscope. Three fields were chosen from the rostral, middle, and caudal ends of each vessel and nerve fiber density was quantified using established methods of image analysis Cowen and Thrasivoulou, 1992) . A Kontron IPS image analyzer was interfaced to the microscope via a low-light video camera (model VL350, PC0 Computer Optics GmbH, Germany). An image of the nerve plexus was taken into the image analyzer. The gain setting and integration time of the camera were set so that the maximum intensity of the images to be analyzed did not exceed the maximum gray value of 255. Images were subject to background subtraction and standard image enhancement and thresholding routines. The resulting binary image of the nerve plexus was measured automatically using established parameters.
Expression of nerve density. Two parameters of nerve density, percentage of area (area%) and intercept density (ID), were measured on all vessels. Area% represents the percentage ofthe vessel surface covered by nerves. Changes in area% can be due to an increase in number of nerve bundles, an increase in the size ofnerve bundles, or a combination of the two. ID measures the number of nerve bundles, irrespective of size, which intercept a grid placed at right angles to the vessel axis and is expressed as ID per millimeter. The fraction area%/intercent density gives a figure propo-rtional to the average size ofnerve bundles. Statistical comparisons between nerve densities were made using one-way ANO-VA.
Results
Target-speciJc nervejiber atrophy of sympathetic and nonsympathetic nerves in old age
The pattern of PGP-immunoreactive (-IR) nerve plexuses on the cerebral arteries showed changes with age ( Fig. 1) . Younger vessels had both large, longitudinally orientated, "paravascular" nerve bundles located in the superficial adventitia and fine, randomly orientated, "perivascular" nerve fibers located at the adventitial-medial border. In contrast, older vessels had predominately fine, perivascular nerve fibers forming a relatively random plexus. The PGP-IR nerve plexus of the tail vein was less dense than the cerebral arteries described above but was more dense than the other two veins. It had both peri-and paravascular components (Fig. 2) . The nerve plexuses to the portal vein and the superior vena cava had similar patterns of innervation consisting of relatively sparse, randomly orientated, thick and fine nerve bundles. Different patterns of nerve plexus were obtained with noradrenaline histochemistry. Whereas PGP-IR nerve bundles were both thick and fine, noradrenergic nerve bundles were mostly fine (Fig. 3) Figure 1 . Photomicrographs showing the total nerve plexus of the middle cerebral artery through development and aging. Nerve bundles were visualized using indirect immunohistochemistry with the general neuronal marker PGP9.5. and a secondary antibody conjugated with FITC. In old age the nerve plexus becomes visibly less dense and contains few large nerve bundles. The axis of the vessel runs from right to left. The nerve plexus was investigated at 6 weeks (a), 7 months(b), and 24 months of age (c). Scale bar, 50 pm.
fibers of transit to other areas of the blood vessel and nonsympathetic nerve fibers. The density of the noradrenergic innervation was similar to that obtained by PGP, suggesting that sympathetic nerves are the most profuse in the perivascular plexus (Todd, 1980; Mione et al., 1988) . However, comparisons of nerve densities visualized with different staining techniques are unreliable because of differing levels of contrast and stain intensity (Webster et al., 199 1) . In whole-mount preparations Figure 2 . Photomicrographs showing the total nerve plexus of the tail vein through development and aging. Nerve bundles were visualized using indirect immunohistochemistry with the general neuronal marker PGP9.5. and a secondary antibody conjugated with FITC. Two types of nerve bundles can be identified: large, superficial "paravascular" nerves and smaller, "perivascular" nerves. In old age the nerve plexus becomes visibly less dense. The axis of the vessel runs from top to bottom in a and b and from right to left in c. Nerve plexuses were investigated at 6 weeks (a), 7 months(b), and 24 months of age (c). Scale bar, 50 pm.
of the portal vein, immunohistochemistry using PGP9.5 only tempted to evaluate changes in the total nerve population supdetected the superficial nerve plexus, in contrast to noradrenplying a segment of the vessel wall. The circumference of each aline histochemistry, where both the superficial and intramusvessel was measured and multiplied by its PGP-IR nerve ID to cular nerve plexus were detected.
give a number representing the total ID. Because the size of blood vessels changed with age, we atWe showed that significant age-related nerve fiber atrophy and Cowen * NGF Can Reverse Nerve Fiber Atrophy in Old Age Figure 3 . Photomicrographs showing the sympathetic innervation of the middle cerebral artery and the tail vein through development and aging. Sympathetic nerves were identified using noradrenaline histochemistry on the middle cerebral artery (a, c) and the tail vein (b, d). Nerve plexuses were investigated at 6 weeks (a, b) and 24 months (c, d) of age. Note that the relatively thick nerve bundles are less prominent with noradrenaline histochemistry. The axis of the vessels runs from top to bottom. There is a visible decrease in the nerve density of the middle cerebral artery with age in contrast to the increased nerve density of the tail vein. Scale bar, 50 pm. occurred in the middle cerebral artery and tail vein. In the seen in the "total" innervation of the middle cerebral artery is middle cerebral artery there was a 50% decrease in the density primarily due to loss of sympathetic fibers from the nerve plexus. of PGP-IR nerves (Fig. 4) In the tail vein, the density of PGP-IR nerve plexuses dedecrease in the total ID after compensation for age-related growth creased by about 50% in old age (Fig. 4) Graph showing the density of peripheral nerves supplying different blood vessels through development and aging. Nerves were detected using indirect immunohistochemistry with the general neuronal marker PGP9.5. Images of the nerve plexus were quantified using image analysis. ID represents the number of nerve bundles that innervate a grid placed a right angles to the vessels axis and is expressed as intercepts per millimeter.
There was a significant decrease in the density ofthe middle cerebral artery (p < O.OOl), the basilar artery (p < O.OOl), and the tail vein (p < 0.001) with age (1.5 vs 24 months) but no change in the portal vein or superior vena cava. Error bars show SEM; n = 8 for all groups. MCA, middle cerebral artery; Basilar, basilar artery; Portal, portal vein; WC, superior vena cava. 5, p < 0.001). This implies that fiber atrophy in the PGP-IR nerve plexus is due to loss of nonsympathetic nerves that are presumably sensory or parasympathetic.
No evidence of PGP-IR or noradrenergic nerve fiber loss was seen on the superior vena cava.
NGF treatment on young and aged perivascular nerves
In order to avoid confusing changes in neuroactive substances with nerve fiber growth and atrophy, we have used PGP9.5 exclusively for the evaluation of nerve density in NGF treated nerve fibers. We did not observe any obvious changes in the stain intensity of PGP-IR nerves with age or following NGF treatment.
NGF treatment for 2 weeks induced a change in the pattern of innervation in old cerebral arteries as demonstrated by PGP-IR (Fig. 6) . The typical PGP-IR nerve plexus on aged cerebral blood vessels is comprised of a sparse, randomly orientated network of fine nerve bundles (see Fig. 1 Figure 5 . Graph showing the density of sympathetic nerves supplying different blood vessels through development and aging. Sympathetic nerves were detected using noradrenaline histochemistry. Images of the nerve plexus were quantified using image analysis. ID represents the number of nerve bundles that innervate a grid placed a right angles to the vessels axis and is expressed as intercepts per millimeter.
There was a significant decrease in the sympathetic nerve density on the middle cerebral artery (p < 0.001) and the basilar artery (p < 0.001) but an increase on the tail vein (p < 0.005) with age (1.5 vs 24 months). There was no change in the innervation density of the portal vein or superior vena cava. Error bars show SEM; n = 8 for all groups. MCA, middle cerebral artery; Basilar, basilar artery; Portal, portal vein; SVC, superior vena cava.
arranged nerve bundles overlying a network of fine, dense, randomly orientated nerves resembling the pattern seen on young vessels.
The effect of NGF on the density of perivascular nerves from young and aged cerebral blood vessels is summarized in Figure  7 . In the old middle cerebral artery, NGF increased the area% of PGP-IR nerves relative to untreated vessels (205%, p < 0.00 1) and cyt C vehicle-treated controls (p < 0.05). Furthermore, NGF caused a significant increase in the ID of PGP-IR nerves on old middle cerebral artery relative to untreated (85%, p < 0.005) and cyt C vehicle-treated controls (p < 0.05). Because the increase in the area% of PGP-IR nerves was larger than the increase in the ID we can infer (see Expression of nerve density, in Materials and Methods) that NGF increased both the size and number ofnerve bundles. Interestingly, cyt C vehicle caused a significant increase in area% (116%, p < 0.0 1) but not ID of PGP-IR nerves on the old middle cerebral artery, suggesting Figure 6 . Photomicrographs showing the nerve plexus of the middle cerebral artery following treatment with cyt C and NGF. NGF (c, d) and cyt C (a. b) was infused over the nerve plexus of the middle cerebral artery in 6 week (young) (a, c) and 24 month (aged) (b, d) rats for 2 weeks. Nerve bundles were visualized using indirect immunohistochemistry with the general neuronal marker PGP9.5. and a secondary antibody conjugated to FITC. NGF induced aged neurons to regrow with a pattern of innervation resembling that seen in young animals. Image analysis was used to analyze the density of innervation. The axis of the vessels runs from top to bottom. Scale bar, 50 pm.
that vehicle-induced nerve growth was restricted to an enlargement of existing nerve bundles.
In the young middle cerebral artery, NGF increased the area% of PGP-IR nerves relative to untreated (74%, p < 0.005) and cyt C-treated (p < 0.05) vessels. However, the ID was not affected. This implies that NGF infusion caused an increase in the size, but not the number, of nerve bundles on the young middle cerebral artery. Cyt C vehicle had no significant effect on the PGP-IR nerve density.
A previous study has shown that the vascular nerve plexus of the posterior cerebral artery, like the middle cerebral artery, also displays age-related nerve fiber atrophy (Cowen and Thrasivoulou, 1990 ). In the old posterior cerebral artery NGF induced a significant increase in the area% (52%) and ID (77%) of PGP-IR nerves relative to untreated (p < 0.001) and cyt C vehicle-treated (p < 0.001) vessels. NGF increased the ID more than the area%, inferring that the increase in nerve density is due to an increase in new nerve bundles and not to increased . NGF or cyt C was infused over the nerve plexus of the middle cerebral artery for 2 weeks in young (6 week) and aged (24 months) rats. Nerves were detected using indirect immunohistochemistry with the general neuronal marker PGP9.5. Images of the nerve plexus were quantified using image analysis. Control represents the untreated vessels. Area% is the proportion of blood vessel wall covered by nerves, irrespective of their number. Intercept density (ID) represents the number of nerve bundles that intersect a grid placed at right angles to the vessels axis and is expressed as intercepts per millimeter. a, In the middle cerebral artery NGF induced an increase in the number (ID) and size (Area%) of nerve bundles on old arteries but only induced an increase in the size (Area%) of nerve bundles young arteries. b, In the posterior cerebral artery NGF induces an increase in the Area% and ID of the old nerve plexus. Error bars show SEM. In a (middle cerebral artery), for Young data, Control, n = 8; Cytochrome C, n = 5; NGF, n = 4; for Old data, Control, n = 8; Cytochrome C, n = 5; NGF, n = 6. In b (posterior cerebral artery), for Young data, Control, n = 6; Cytochrome C, n = 4; NGF, n = 4; for Old data, Control, n = 6; Cytochrome C, n = 5; NGF, n = 6. Significance between adjacent groups was tested using ANOVA (*, p < 0.05; **, p < 0.01; ***, p i 0.001).
size of existing nerve bundles. Cyt C vehicle had no effect on because of the greater distance of the posterior cerebral artery nerve density.
from the site of infusion. In the young posterior cerebral artery, NGF induced a significant increase in the area% of PGP-IR nerves relative to untreated (41%, p < 0.05) but not to cyt C-treated vessels. ID of PGP-IR nerves was not affected. Cyt C vehicle had no effect on the PGP-IR nerve density. Therefore, in both the young middle and posterior cerebral arteries, NGF caused an increase in nerve bundle size but not in number. The increases in nerve density seen on the posterior cerebral artery following NGF treatment were less than on the middle cerebral artery, probably
Discussion
In an attempt to reverse the nerve fiber atrophy exhibited by some neurons in old age, we have infused NGF in vivo over their peripheral nerve fibers in old freely moving rats. The results described here demonstrate that the exogenous application of NGF in vivo to an aged nerve plexus can induce growth and regeneration of a pattern of innervation that resembles that seen in young animals. Target-specijic nature of nerve fiber atrophy The elucidation of the primary causative factors involved in neuronal atrophy is of fundamental importance in aging research. Rather than being a general phenomenon, neuronal atrophy is a temporally and spatially specific feature of the aged nervous system (Cotman and Holets, 1985; Giacobini, 1988; Selkoe, 1992) . Furthermore, age changes in phenotypically similar neurons are species specific (Finch, 1993) . The peripheral innervation of the vasculature provides a model system for studying neuronal atrophy with detailed descriptions of agerelated changes demonstrating spatial, temporal and species specificity Dhall et al., 1986; Mione et al., 1988; for review, see Cowen, 1993b) . The vascular nerve plexus contains sympathetic, sensory, and parasympathetic nerves. Nerve fiber loss combined with reduced neurotransmitter content in residual fibers has been previously demonstrated in the posterior cerebral artery (Cowen and Thrasivoulou, 1990) . In this study we show that although nerve fiber loss was seen on the middle cerebral artery and tail vein, it was not universal. Furthermore, while nerve fiber loss in the middle cerebral artery was caused primarily by the atrophy of sympathetic nerve fibers, in the tail vein the number of sympathetic nerves increased in old age while the overall (PGP-IR) innervation declined, suggesting a substantial loss of sensory and/or parasympathetic nerves. The hypertrophy of the sympathetic innervation on the tail vein in old age reveals the continued plasticity of aging neurons and corroborates other studies showing that age changes are not always degenerative (Buell and Coleman, 1979) . These opening results reinforce the concept of heterogeneity in neuronal age changes.
Recent studies using in oculo transplantation have shown that age-related loss of some peripheral nerve fibers including those supplying cerebral blood vessels is primarily the result of changes in their non-neuronal peripheral target (Gavazzi et al., 1992) . Further experiments have indicated retained plasticity of the aging neurons that innervate these targets (Crutcher, 1990; Suhonen et al., 1991; Gavazzi and Cowen, 1993a) , strengthening the idea that changes in target tissues induce neuronal atrophy. We hypothesize that the region-specific changes in neuronal morphology that we and others have described in peripheral nerves is a result of decreased availability of target-derived factors such as NGF.
NGF and neuronal aging The role oftarget-derived
NGFin the survival and development of neurons is well established (for review, see Bjerre et al., 1975; Levi-Montalcini, 1987; Yankner and Shooter, 1982; Thoenen, 199 1) . Levels of NGF in target tissues have been shown to correlate well with the density of their innervation (Korsching and Thoenen, 1983; Shelton and Reichardt, 1984) . Central and peripheral neurons continue to require NGF for their survival and maintenance in old age (Montero and Hefti, 1989; Ruit et al., 1990; Sofroniew et al., 1990) . However, to our knowledge, NGF treatment has not been used in vivo on specific populations of neurons where fiber atrophy has been characterized and quantitatively defined. We show that following NGF treatment the aged nerve plexus regenerates large longitudinally orientated nerve bundles as well as additional perivascular fibers, that is, a pattern and density resembling that seen on young blood vessels. This observation demonstrates the ability ofNGF to induce organotypic neurite outgrowth from aged neurons in vivo. Further evidence for the ability of NGF to restore organotypic patterns of reinnervation comes from a recent study looking at the reinnervation of transplanted old cerebral blood vessels in oculo (Gavazzi and Cowen, 1993b) . However, although the pattern of nerve growth that we observed in NGF-treated old cerebral arteries resembled that seen in young tissues, we do not know if the nerve growth was phenotypically appropriate; that is, were sympathetic nerves stimulated to regrow more than sensory nerves? However, a recent study has shown that NGFinduced sprouting of nerves on young-adult cerebral blood vessels is largely prevented by sympathectomy (Issacson et al., 1992) . There is increasing evidence to show that cerebral blood vessels can be innervated by neurons of central origin. The cholinergic neurons of the basal forebrain have been shown to innervate the vasculature of the neocortex and hippocampus (Sato and Sato, 1992) . Interestingly, these neurons have been shown to be dependent on NGF for their development and survival (Montero and Hefti, 1989; Sofroniew et al., 1990 ) and may also sprout in response to NGF infusion.
A decrease in the availability of neurotrophic factors has been linked with changes that take place in neurodegenerative diseases and normal aging (Bartus et al., 1982; Varon et al., 1988; Perez-Polo et al., 1990) . NGF has been linked with the neurodegenerative changes that take place in the NGF-sensitive neurons of the basal forebrain during Alzheimer's disease (Appel, 198 1). However, a clear connection between decreased NGF levels and neuronal atrophy remains to be established. A major problem has been the conflicting evidence for age-related changes in NGF in specified areas of the nervous system such as the aged neocortex, where there is evidence of decreased (Larkfors et al., 1987; Alberch et al., 1991) and unchanged (Goedert et al., 1986; Hellweg et al., 1990 ) levels of NGF and NGF mRNA. The discovery of a high-affinity NGF receptor (NGFr), the protooncogene trk (Hempstead et al., 199 1; Klein et al., 199 l) , has led to speculation that NGFr and not NGFmay be the important factor in neuronal aging (Hefti and Mash, 1989) . A loss ofNGFr has been reported in sympathetic ganglia from aged mice (Uchida and Tomonaga, 1987) . NGF levels have been shown to regulate the expression of NGFr (Miller et al., 199 1; Holtzman et al., 1992) and a decrease in NGF levels could explain the loss of NGFr seen in that study. However, NGF levels have not been studied in peripheral tissues of aging rats, and we cannot conclude from our results that a decrease in NGF availability causes the nerve fiber atrophy we have observed. Nonetheless, the ability of exogenous NGF to reverse age-related neurodegenerative changes with organotypic patterns of nerve regrowth provides circumstantial evidence for its role in vivo. However, we do not rule out that other aspects of the target may be involved such as extracellular matrix (Sanes, 1989) or neurotrophic factors other than NGF (Thoenen, 199 1) .
The efect of NGF on young versus old neurons NGF had different effects on neurite outgrowth from old and young neurons. NGF induced more outgrowth from aged neurons, despite their ongoing fiber atrophy, compared to young nerves, suggesting that old nerves retain a substantial capacity for regrowth. This result contrasts with in vitro studies that show reduced neurite growth ofaged sympathetic and sensory neurons in response to NGF (Uchida and Tomonaga, 1985a; Tanaka et al., 1990 ). However, in vivo studies have shown that the capacity of sympathetic neurons for neurite outgrowth is unaffected by age (Crutcher, 1990; Gavazzi and Cowen, 1993a) . The expla-nation for the discrepancies between in vitro and in vivo studies may lie in the in vitro demonstration that the ability of NGF to elicit neurite outgrowth from young and aged sympathetic neurons depends on the substratum the neurons are grown on (Uchida and Tomonaga, 1985b) , suggesting that trophic factors and extracellular matrix act synergistically in peripheral nerve growth.
Young and aged neurons responded differently to NGF in their manner of neurite outgrowth. NGF increased both the size and number of nerve bundles from aged animals but only increased the size of nerve bundles from young animals. Thus, neurite outgrowth from old neurons occurs along new as well as existing pathways, whereas nerve growth from young neurons occurs principally along existing pathways. Growing axons interact with growth-promoting components of the extracellular matrix such as laminin, via cell surface receptors such as integrins and with other axons and schwann cells via cell adhesion molecules. NGF is known to influence the expression of cell surface receptor molecules (Rossino et al., 1990) . It is possible that NGF upregulates receptor molecules on old nerves favoring both fasciculation and sprouting, whereas it only upregulates receptors concerned with fasciculation in young nerves.
Vehicle infusion induces nerve growth Cyt C-containing vehicle solutions have been used in studies of NGF as a control with no neurogenic effects (Isaacson et al., 1990; Ruit et al., 1990; Saffran and Crutcher, 1990) . However, in this study, an increase in nerve density was seen in the vehicleinfused, aged middle cerebral artery, albeit less than that produced by NGF. A recent investigation in our laboratory has shown that exogenous bovine serum albumin but not rat serum albumin induces increased nerve outgrowth from rat autonomic neurons (Gavazzi and Cowen, 1993b) . This leads us to suggest that an immune or inflammatory reaction, induced or potentiated by the invasive surgery, could directly or indirectly generate nerve growth. Possible mechanisms could include the upregulation of NGF synthesis in fibroblasts by cytokines produced by invading cells of the immune system (Yoshida and Gage, 1992) .
In conclusion, we have demonstrated the region-specific nature of nerve fiber atrophy as it effects the perivascular nerves of peripheral neurons, and have shown that different subpopulations of nerve fibers degenerate in different tissues. We have gone on to show that NGF can induce organotypic regrowth of degenerating nerves in aged rats. It has been suggested that NGF could be used as a therapeutic agent in human neurodegenerative diseases (Tuszynski et al., 1991) . This study shows the potential of exogenous NGF to reverse age-related deficits in neuronal morphology. However, as yet we do not know whether the pattern of NGF-induced nerve regrowth is phenotypically appropriate or functional.
